Discover How Prostate Cancer Is Detected: PSA Test and Screening Insights
Tim Jewell
Tim Jewell 3 years ago
Medical Writer & Communications Specialist #Sexual Wellness
0
4.6K

Discover How Prostate Cancer Is Detected: PSA Test and Screening Insights

Explore the essential methods for detecting prostate cancer, including PSA tests and digital rectal exams, and understand the benefits and risks of screening.

Prostate cancer affects the prostate gland, a small but vital organ found in individuals with a penis. This gland produces fluids that aid in sperm transport during ejaculation.

Globally, about 1.28 million new prostate cancer cases are diagnosed annually, making it a common health concern.

While prostate cancer can be life-threatening, especially for those over 75, early detection significantly improves treatment success before cancer spreads to nearby tissues.

Regular and early screening plays a crucial role in identifying prostate cancer, including aggressive types, allowing timely intervention.

Continue reading to learn about prostate cancer detection methods, screening advantages and disadvantages, and guidance following a diagnosis.

Methods for Prostate Cancer Screening

Healthcare providers primarily use two tests to screen for prostate cancer:

Prostate-Specific Antigen (PSA) Test

The PSA test measures the level of prostate-specific antigen in your blood, a protein produced by the prostate. Elevated PSA levels can indicate the presence of prostate cancer, although normal levels vary with age and individual factors.

Typically, PSA levels above 4.0 ng/mL raise concerns, but doctors consider trends and other risk factors when interpreting results.

The PSA test involves a simple blood draw at a lab, where a small needle collects blood from your arm. Results are usually available within a few days to two weeks and are shared through your healthcare provider.

Digital Rectal Exam (DRE)

A doctor performs a DRE by gently inserting a lubricated, gloved finger into the rectum to feel the prostate gland for irregularities such as lumps or hard areas that might suggest cancer.

This physical exam complements PSA testing and helps detect abnormalities that might not elevate PSA levels.

Who Should Consider Prostate Cancer Screening?

The American Cancer Society advises discussing prostate cancer screening with your healthcare provider to weigh the benefits and risks based on your personal risk profile.

Recommended Age Group: 55 to 69 Years

Screening is generally advised for men aged 55 to 69, as prostate cancer risk increases with age. Screening younger than 40 is uncommon unless high risk factors exist, and screening after 70 may offer limited benefits.

Screening Frequency

For those without symptoms or high risk, screening every two years is typical; more frequent testing may be necessary if symptoms or elevated risk factors are present.

Early Screening for High-Risk Individuals

Men with a family history of prostate cancer or African American men may start screening at age 40 due to increased risk.

Recognizing Prostate Cancer Symptoms

Common symptoms include frequent urination, burning during urination, difficulty starting urination, weak urine flow, blood in urine, pain during erection or ejaculation, and unexplained pain in hips, back, or thighs. Consult a doctor promptly if multiple symptoms occur.

Pros and Cons of Prostate Cancer Screening

Screening can save lives by detecting cancer early but may also lead to overdiagnosis and unnecessary treatments.

Research shows PSA testing prevents approximately 3 deaths per 1,000 men screened but may cause overdiagnosis in 60 per 1,000, leading to avoidable side effects like urinary issues and erectile dysfunction.

Additional tests following positive screenings, such as biopsies, are minimally invasive but carry risks like infection or bleeding.

Discuss with your doctor to determine if screening aligns with your health goals.

Advantages of Screening

  • Provides reassurance if results are negative, especially for high-risk individuals.
  • Detects cancer before symptoms develop.
  • Early detection improves treatment outcomes.

Disadvantages of Screening

  • False positives can cause anxiety and lead to unnecessary procedures.
  • False negatives may delay diagnosis.
  • Detection of slow-growing cancers that may never cause symptoms, resulting in overtreatment.

Confirming a Prostate Cancer Diagnosis

If initial tests suggest prostate cancer, doctors may perform further evaluations:

Biopsy

A small needle extracts tissue samples from the prostate for laboratory analysis to confirm cancer presence.

Proctoscopy

A lighted tube with a camera is inserted into the rectum to inspect the prostate area and collect biopsy samples if needed.

Sigmoidoscopy

This procedure examines the sigmoid colon and can detect abnormalities near the prostate.

Colonoscopy

Used if cancer spread is suspected or gastrointestinal symptoms exist, this exam inspects the entire colon for tumors or polyps.

After Diagnosis: What to Expect

Doctors will determine cancer stage and recommend treatment options accordingly.

Staging

Staging assesses cancer advancement from 1 (localized) to 4 (spread beyond the prostate), based on tumor size, lymph node involvement, and metastasis.

PSA levels and Gleason scores, indicating cancer aggressiveness, also guide treatment planning.

Treatment Options

Early-stage prostate cancer may be managed with active surveillance, involving regular monitoring without immediate treatment.

For more advanced stages, treatments include:

  • Radical prostatectomy (surgical removal of the prostate)
  • Cryosurgery (freezing and destroying cancer cells)
  • Transurethral resection (removal of obstructive tissue via the urethra)
  • Radiation therapy
  • Hormone therapy to reduce testosterone levels
  • Immunotherapy to boost the immune response against cancer cells

Prostate Cancer Outlook

The 5-year survival rate varies by cancer stage:

  • Localized: over 99% survival
  • Regional spread: over 99% survival
  • Distant metastasis: approximately 31% survival

Early and regular screening can reduce prostate cancer mortality by nearly half, emphasizing the importance of timely detection.

Summary

Prostate cancer is a prevalent condition that is often highly treatable when identified early. Routine screenings starting at age 55, or earlier for high-risk individuals, can greatly improve outcomes and save lives.

Explore useful articles in Sexual Wellness as of 28-10-2022. The article titled " Discover How Prostate Cancer Is Detected: PSA Test and Screening Insights " offers in-depth analysis and practical advice in the Sexual Wellness field. Each article is carefully crafted by experts to provide maximum value to readers.

The " Discover How Prostate Cancer Is Detected: PSA Test and Screening Insights " article expands your knowledge in Sexual Wellness, keeps you informed about the latest developments, and helps you make well-informed decisions. Each article is based on unique content, ensuring originality and quality.

0
4.6K

InLiber is a global news platform delivering fast, accurate, and trustworthy information from around the world.

We cover breaking news and insights across technology, politics, health, sports, culture, finance, and more. Designed for all internet users, InLiber provides a user-friendly interface, verified sources, and in-depth coverage to keep you informed in the digital age.